Gabapentin is prescribed widely for nerve pain, certain seizure disorders, restless legs syndrome, and a range of off-label uses including anxiety and chronic pain. It has a long safety record, and the side effects people are usually counseled about are drowsiness, dizziness, and swelling in the legs. Hair loss is not on that list, which is exactly why it can be unsettling when someone notices more shedding a few weeks after starting the drug and finds nothing about it in the leaflet. The evidence-based answer is reassuring in its overall shape but honest about its limits: gabapentin-associated hair loss appears to be real, it is rare, and the published record consists of a small number of case reports rather than large studies. This guide walks through what those reports actually show, the mechanism most likely at play, and how the situation is usually approached.
What the evidence shows about gabapentin and hair
Hair loss is not listed as a common adverse reaction in gabapentin's FDA prescribing information. Where it appears at all, it sits among the rare skin and appendage events as a "hair disorder," which signals that the manufacturer logged occasional reports during surveillance without it rising to the level of a recognized side effect. That gap is part of why patients who experience shedding have no frame of reference for what they are seeing.
The clinical literature is small. The first documented case was published in 1997, describing a patient who developed hair loss after starting gabapentin and recovered after stopping it (Picard et al., Ann Pharmacother, 1997). A later case in the palliative care setting described alopecia in a patient taking gabapentin for neuropathic pain, again with the timeline pointing toward the drug (Hauben, J Pain Symptom Manage, 2008). More recent case reports have continued to surface in the pain literature, but the total number of formally reported cases attributed to gabapentin remains in the single digits. Compared with the millions of prescriptions written each year, that is an extremely low signal.
So the accurate framing is not "gabapentin causes hair loss" but rather "a small number of people appear to shed hair while taking gabapentin, the association is biologically plausible, and it is uncommon enough that it has never shown up as a statistical side effect in the drug's trials."
The likely mechanism: telogen effluvium
In the cases that have been documented, the hair loss was consistently diffuse and non-scarring rather than patterned. That description fits telogen effluvium, the most common form of drug-related and stress-related shedding. In telogen effluvium, a trigger pushes an abnormal share of follicles out of their active growth phase and into the resting (telogen) phase at the same time. Those follicles release their hairs together two to three months later, which is why the shedding shows up weeks after the trigger rather than immediately.
The reported gabapentin cases line up with this timing. Onset was generally within the first two months of starting the medication, and in at least one case the change was noticed within about a week, which is fast but still within the range seen when a drug acts as an acute follicular stressor. Just as importantly, the shedding reversed after the drug was stopped, with hair regrowing once the follicles cycled back into their growth phase. Reversibility on withdrawal is one of the features that makes a drug-effect explanation more convincing than coincidence.
It is worth being clear about what telogen effluvium is not. It is a synchronized shedding of existing hair, not destruction of the follicle. That is why recovery is the expected outcome once the trigger is removed, and why this pattern is fundamentally different from androgenetic alopecia, which involves the gradual miniaturization of follicles over years.
Why the timing can be misleading
One reason gabapentin is hard to pin down as a cause is that the people who take it often have other things happening at the same time that can independently trigger shedding. Gabapentin is frequently started during a period of significant illness, injury, surgery, or chronic pain, and each of those is a well-established telogen effluvium trigger on its own. A patient recovering from surgery, sleeping poorly because of nerve pain, and starting a new medication has at least three plausible shedding triggers stacked together, and the medication is simply the most visible one.
This is the same interpretive problem that comes up across the medication-and-shedding cluster. The guides on antidepressants and hair loss and metformin and hair loss both run into it: the drug gets the blame because it is new and concrete, while the underlying health event that prompted the prescription may be doing as much or more of the work. Telling these apart usually requires looking at the full timeline rather than the medication alone.
What to do if you notice shedding on gabapentin
The most important step is not to stop a prescribed medication on your own. Gabapentin is often treating a condition where abrupt discontinuation carries real risk, and any change to the dose or schedule should be made with the prescribing clinician. Bring the hair concern to them directly so the decision is made with the full picture in view.
A few things are worth discussing at that visit:
- The timeline. When did the shedding start relative to the medication, and relative to any illness, surgery, weight change, or major stressor? A clear two to three month gap after a single trigger points toward telogen effluvium.
- The pattern. Diffuse shedding across the whole scalp is consistent with a telogen effluvium and a possible drug effect. Loss concentrated at the crown, temples, or part line points instead toward pattern hair loss, which the medication did not cause.
- Other contributors. Iron and ferritin, thyroid function, recent crash dieting, and other new medications are all worth reviewing, because correcting a co-existing cause is often more productive than focusing on the gabapentin alone.
If a clinician does suspect the gabapentin and the underlying condition allows it, they may consider adjusting the dose or trying an alternative. Because the documented cases recovered after stopping the drug, that is generally the expected trajectory, with regrowth becoming visible over the following several months rather than immediately.
What if it turns out to be pattern hair loss?
Sometimes a shedding episode is what finally makes someone look closely at their scalp, and what they find is not a temporary drug-related shed but early androgenetic alopecia that was progressing quietly underneath. The two can coexist. A telogen effluvium from any trigger can unmask pattern thinning that was already underway, because the temporary shed makes the gradual loss suddenly obvious.
The distinction matters because the management is different. A drug-related telogen effluvium typically resolves once the trigger is addressed and time passes. Pattern hair loss does not resolve on its own and has its own evidence-based treatment options, which a physician can review based on the specific pattern and history. A scalp exam is the most reliable way to tell which picture is in front of you.
If your shedding is diffuse, recent, and clearly tied to a new medication or health event, time and addressing the trigger are usually the answer. If the loss is concentrated at the temples, crown, or part line and has been creeping along for a while, that is worth a separate conversation. Curekey's hair assessment is one way to start that conversation with a U.S.-licensed physician.
Related reading
- Do antidepressants cause hair loss?: the sibling article on a class of drugs with the same telogen effluvium pattern.
- Does metformin cause hair loss?: another medication-and-shedding explainer where timing and co-existing causes complicate the picture.
- Stress and hair loss: telogen effluvium: the cycle-based explanation for the most common cause of acute, reversible shedding.
- What DHT is and why it causes pattern hair loss: how to recognize the patterned loss that a shedding episode can unmask.
- How it works: what a Curekey assessment and physician review look like.
